Company / EPS (Diluted)
LivaNova EPS (Diluted) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
$0.32
FY2025
5-year range
-$7.18 / $0.32
FY2021-FY2025
Trend
+119.9%
vs FY2024
Sector context
#90 of 159
Health Care
What the data says
At $0.32, LivaNova's eps (diluted) ranks #90 of 159 in the Health Care sector. EPS (Diluted) has increased for 3 consecutive years, from $-7.18 in FY2022 to $0.32 in FY2025.
Based on SEC 10-K filings.
0.32 in FY2025.
Improved from $-2.68 to $0.32 over the past 2 years.
Health Care sector context is included.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#90 of 159 in Health CareTop 57% of 159This company $0.32 Sector average $1.67
▼
-80.8% below sector average
Key checks
Key Insights
- LivaNova's eps (diluted) has grown for 3 consecutive years.
- In FY2025, eps (diluted) increased 119.9% year-over-year.
- Ranks #90 out of 159 companies in the Health Care sector.
- Peak eps (diluted) was recorded in FY2016.
Company context
Key Data Points
- Altman Z-Score 0.84 (distress zone, below 1.8 threshold)
- Negative profit margin: -16.1%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.32 | +119.9% |
| FY2024 | -$1.61 | +39.9% |
| FY2023 | -$2.68 | +62.7% |
| FY2022 | -$7.18 | -120.2% |
| FY2021 | -$3.26 | +16.6% |
| FY2020 | -$3.91 | -651.9% |
| FY2019 | -$0.52 | +59.4% |
| FY2018 | -$1.28 | -197.7% |
| FY2017 | $1.31 | -34.5% |
| FY2016 | $2.00 | +322.2% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026